Hungarian Court Decision Threatens Unified Patent Court Viability
Hungary has decided that Europe’s forthcoming Unified Patent Court Agreement is not compatible with its constitution. It will now be more important than ever to keep a close watch for possible new constitutional complaints in other countries.
You may also be interested in...
The latest “technical notices” from the government say that there will be no material change to the rules on intellectual property protections and compulsory licensing if the UK leaves the EU without a deal, and that the government also intends to continue allowing parallel imports of medicines from Europe to the UK.
Europe’s UPC still cannot start until and unless a legal challenge in Germany is settled in favor of the court, but the UK’s ratification this week means that discussions about the UK’s post-Brexit participation in the new systemcan now start properly.
MSD has agreed to restrict the use of its Keytruda combination therapy in a manner that means that Roche’s Tecentriq combination is no longer a direct comparator.